ESR1 and COVID-19: Taken together, these data suggest that ER modulation may be a suitable pharmacological approach for preventing/attenuating the cytokine storm and inflammation associated with COVID-19 and in particular the use of SERMs and/or “tissue selective estrogen complex” (TSEC, i.e. association of SERM and natural estrogen) may represent a promising pharmacological option.